Bumetanide and Encephalopathy - a phase IV clinical study of FDA data

Summary:

Encephalopathy is reported as a side effect among people who take Bumetanide (bumetanide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lorazepam, and have Pain.

The phase IV clinical study analyzes which people have Encephalopathy when taking Bumetanide. It is created by eHealthMe based on reports of 20,353 people who have side effects when taking Bumetanide from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Encephalopathy?

Encephalopathy (functioning of the brain is affected by some agent or condition) is found to be associated with 1,459 drugs and 1,606 conditions by eHealthMe. Check the latest studies of Encephalopathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

20,353 people reported to have side effects when taking Bumetanide.
Among them, 84 people (0.41%) have Encephalopathy.

Among these 84 people:

How long have people been on Bumetanide when they have Encephalopathy? *

What is the gender of people who have Encephalopathy when taking Bumetanide? *

female: 51.81 %
male: 48.19 %

What is the age of people who have Encephalopathy when taking Bumetanide? *

What are other drugs people take besides Bumetanide? *

What are other side effects people have besides Encephalopathy? *

Cardiac Failure Congestive: 28 people, 33.33%
Anaemia (lack of blood): 28 people, 33.33%
Pain: 24 people, 28.57%
Dizziness: 22 people, 26.19%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 22 people, 26.19%
Weakness: 22 people, 26.19%
Fatigue (feeling of tiredness): 22 people, 26.19%
Stress And Anxiety: 21 people, 25.00%
Osteomyelitis (infection of bone): 20 people, 23.81%
Bone Disorder: 20 people, 23.81%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 17 people, 20.24%
Pain: 17 people, 20.24%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 9 people, 10.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 4.76%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 4.76%
Hepatitis C: 3 people, 3.57%
High Blood Cholesterol: 3 people, 3.57%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 3.57%
Type 2 Diabetes: 3 people, 3.57%
Gastritis (inflammation of stomach): 3 people, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Encephalopathy?

- Check whether Encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bumetanide:

Bumetanide (20,532 reports)

Encephalopathy treatments and more:

Encephalopathy (27,832 reports)

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalopathy:

Encephalopathy (1,459 drugs)

Browse all the conditions that are associated with Encephalopathy:

Encephalopathy (1,606 conditions)

Related publications that referenced our studies

Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .
Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.